{"id":"https://openalex.org/A5086646553","orcid":"https://orcid.org/0000-0003-0426-1956","observed_orcids":["https://orcid.org/0000-0003-0426-1956"],"display_name":"Meysam Seyedifar","raw_author_names":["M. Seyedifar","M. Seyyedifar","MS Seyedifar/Meysam","Meysam Seyedifar"],"full_name":"Meysam Seyedifar","works_count":24,"cited_by_count":163,"summary_stats":{"2yr_mean_citedness":1.0,"h_index":5,"i10_index":4},"ids":{"openalex":"https://openalex.org/A5086646553","orcid":"https://orcid.org/0000-0003-0426-1956","observed_orcids":["https://orcid.org/0000-0003-0426-1956"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4403928282","ror":"https://ror.org/01w4ywr53","display_name":"Pharmaceutical Management and Economics Research Center","country_code":"IR","type":"facility","lineage":["https://openalex.org/I4403928282","https://openalex.org/I4403928403","https://openalex.org/I70640408"]},"years":[2026,2024,2023,2021,2020,2019,2016]},{"institution":{"id":"https://openalex.org/I70640408","ror":"https://ror.org/01c4pz451","display_name":"Tehran University of Medical Sciences","country_code":"IR","type":"education","lineage":["https://openalex.org/I70640408"]},"years":[2026,2024,2023,2021,2020,2019,2018,2016,2015,2013,2012]}],"last_known_institutions":[{"id":"https://openalex.org/I4403928282","ror":"https://ror.org/01w4ywr53","display_name":"Pharmaceutical Management and Economics Research Center","country_code":"IR","type":"facility","lineage":["https://openalex.org/I4403928282","https://openalex.org/I4403928403","https://openalex.org/I70640408"]},{"id":"https://openalex.org/I70640408","ror":"https://ror.org/01c4pz451","display_name":"Tehran University of Medical Sciences","country_code":"IR","type":"education","lineage":["https://openalex.org/I70640408"]}],"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","count":14,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","count":5,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","count":4,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10841","display_name":"Economic and Environmental Valuation","count":3,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","count":3,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T14261","display_name":"Herbal Medicine and Trade Cooperation","value":0.0003128,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","value":3.7e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","value":3.11e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","value":2.16e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","value":2.01e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9370002746582031},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.7444624304771423},{"id":"144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","score":0.6433089375495911},{"id":"134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","score":0.5403962135314941},{"id":"112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","score":0.41190001368522644}],"counts_by_year":[{"year":2009,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2012,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2013,"works_count":1,"oa_works_count":1,"cited_by_count":3},{"year":2014,"works_count":0,"oa_works_count":0,"cited_by_count":6},{"year":2015,"works_count":1,"oa_works_count":0,"cited_by_count":11},{"year":2016,"works_count":1,"oa_works_count":1,"cited_by_count":12},{"year":2017,"works_count":0,"oa_works_count":0,"cited_by_count":13},{"year":2018,"works_count":3,"oa_works_count":3,"cited_by_count":11},{"year":2019,"works_count":1,"oa_works_count":1,"cited_by_count":10},{"year":2020,"works_count":2,"oa_works_count":2,"cited_by_count":18},{"year":2021,"works_count":5,"oa_works_count":3,"cited_by_count":10},{"year":2022,"works_count":1,"oa_works_count":0,"cited_by_count":10},{"year":2023,"works_count":3,"oa_works_count":3,"cited_by_count":12},{"year":2024,"works_count":3,"oa_works_count":2,"cited_by_count":18},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":20},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":8}],"display_name_alternatives":["M. Seyedifar","M. Seyyedifar","MS Seyedifar/Meysam","Meysam Seyedifar"],"block_key":"m seyedifar","works_api_url":"https://api.openalex.org/works?filter=author.id:A5086646553","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5086646553","updated_date":"2026-11-12T13:17:38","created_date":"2016-06-24T00:00:00"}